Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Peptides for Boxing Recovery: Evidence Comparison

BPC-157 Upregulates VEGF, EGF, FGF receptors; promotes angiogenesis and collagen synthesis Rotator cuff tendinopathy, hand ligament microtrauma, TFCC damage Moderate (animal models, limited human trials) 200–500 mcg SubQ 2x daily near injury site or systemical

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • BPC-157
  • Upregulates VEGF, EGF, FGF receptors; promotes angiogenesis and collagen synthesis
  • Rotator cuff tendinopathy, hand ligament microtrauma, TFCC damage
  • Moderate (animal models, limited human trials)
  • 200–500 mcg SubQ 2x daily near injury site or systemically
  • Reduces tendon healing time by ~40% in research models
  • TB-500
  • Binds actin monomers; enhances cell migration and tissue remodeling; downregulates TNF-α
  • Muscle strain recovery, rotator cuff tears, systemic inflammation reduction
  • Moderate (animal models, observational athletic use)
  • 2–2.5 mg SubQ 2x weekly (acute phase), then 2 mg weekly (maintenance)
  • Accelerates muscle injury recovery by ~40% in animal studies
  • CJC-1295/Ipamorelin
  • Stimulates pulsatile GH release; elevates IGF-1; enhances systemic protein synthesis
  • Overall tissue repair, cartilage health, joint inflammation reduction
  • High (human trials for GH dynamics; extrapolated for athletic recovery)
  • 100 mcg each SubQ once daily before sleep
  • Improves lean tissue repair and reduces perceived recovery time in controlled settings
  • MK-677 (Ibutamoren)
  • Oral ghrelin mimetic; sustained GH elevation
  • Chronic joint health, sleep quality improvement, lean mass preservation
  • Moderate (Phase II trials; off-label athletic use)
  • 12.5–25 mg orally once daily
  • Sustained elevation of GH/IGF-1 improves recovery markers over 8–12 weeks
  • Cerebrolysin
  • Neurotrophic peptide blend; promotes BDNF and NGF pathways
  • Neuroprotection from subconcussive impacts, cognitive recovery post-sparring
  • Moderate (human trials in stroke/TBI; extrapolated for sports neuroprotection)
  • 5–10 mL IV or IM 3x weekly during high-volume sparring blocks
  • Reduces neuroinflammatory markers; supports cognitive function under repeated head impacts